---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-067794"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:40:32.672959+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Mirum reports immaterial SVB exposure (<1% of cash)

## Summary
- Less than 1% of cash, equivalents, restricted cash and investments held at SVB.
- SVB placed under FDIC receivership; company believes exposure is immaterial.
- May experience delays in transferring funds due to banking system disruption.
- No other financial impact disclosed as of March 10, 2023.

## SEC filing metadata
- accession: 0001193125-23-067794
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000119312523067794/0001193125-23-067794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000119312523067794/d475671d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-067794
- JSON: https://secwatch.observer/filing/0001193125-23-067794.json
- Plain text: https://secwatch.observer/filing/0001193125-23-067794.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.